(Q46632481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Raymond M Wong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ron R Scotland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Roy L Lau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Changyu Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alan J Korman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jeffrey S Weber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

published in

International Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1223-1234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898045%20AND%20SRC:MED&resulttype=core&format=json

Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Recent developments in therapeutic cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Diversity and recognition efficiency of T cell responses to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Multiple costimulatory modalities enhance CTL avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Functional significance of the perforin/granzyme cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXM091